BPC-157 is popular with biohackers, but the science is thin
A peptide beloved in biohacking communities has fifty years of research behind it. Almost all of it comes from one scientist in one lab.
BPC-157 is a short chain of amino acids, a peptide, said to be derived from a protein found in gastric juice. It has circulated widely in biohacking circles as a remedy for joint pain, digestive issues, and tissue repair. The interest is substantial. But the researchers at STAT News, publishing alongside Undark and supported by the Pulitzer Center, surface an uncomfortable reality: almost all published research on BPC-157 originates from a single laboratory in Zagreb, led by one scientist, Predrag Sikiric, who has worked on it for over fifty years.
That is not evidence that the substance does not work. But it makes independent verification nearly impossible. In science, replication by different groups, in different countries, using different methods, is a core requirement for credibility. For BPC-157, that replication is largely absent. The studies that exist were conducted almost entirely in animals, primarily rats. Human clinical trials are scarce.
A regulatory flashpoint
The popularity of BPC-157 has also created regulatory friction. The FDA has been attempting to assert authority over peptides sold as supplements despite having pharmacological activity. BPC-157 sits at the center of that effort. Proponents, including figures associated with the Make America Healthy Again movement, frame regulation as an infringement on personal choice. Critics point to the absence of safety data in humans.
What the evidence actually shows
The honest summary is: not much is established. Available animal studies suggest effects on tissue repair and gastrointestinal health. The mechanism is not well understood. Whether those effects translate to humans, at what dose, and without harmful side effects, has not been determined. BPC-157 is in that sense an instructive case study in a wider tension within the longevity space: the gap between the popular adoption of supplements and the scientific evidence base that would justify it.